drugset / Trial / NCT03002961
Single Ascending Dose Study of RBP-6000
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A multi-center, open-label, single ascending dose study to enroll opioid dependent treatment-seeking subjects. Subjects to be enrolled into 3 cohorts receiving low, medium and high doses of depot buprenorphine. A fourth cohort will be enrolled to evaluate the PK of RBP-6000 after receiving suboxone tablets for 7 days.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-02
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 12 mg | Other |
| Subject | RBP-6000 | Unknown | — | Subcutaneous |